| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 26.152 | 0 | 10.674 | 3.825 | 0 |
| Total Income - EUR | - | - | - | - | - | 26.152 | 0 | 10.674 | 3.825 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 1.970 | 3.538 | 6.350 | 4.650 | 101 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 24.182 | -3.538 | 4.324 | -825 | -101 |
| Net Profit/Loss - EUR | - | - | - | - | - | 23.476 | -3.538 | 4.020 | -825 | -101 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medical Science Consultancy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 615 | 1.385 | 1.143 | 895 | 647 |
| Current Assets | - | - | - | - | - | 22.903 | 15.138 | 20.232 | 19.334 | 19.103 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 4.439 | 4.130 | 14.551 | 13.331 | 13.135 |
| Cash | - | - | - | - | - | 18.464 | 11.008 | 5.681 | 6.002 | 5.969 |
| Shareholders Funds | - | - | - | - | - | 23.518 | 15.984 | 20.054 | 19.167 | 18.959 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 0 | 538 | 1.322 | 1.062 | 791 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Medical Science Consultancy S.r.l.